Johnson & Johnson
JNJ
Delayed Nyse - 07/20 10:00:31 pm
125.85USD
-0.07%
Prev.125.9400
Open125.3000
High126.1400
Low125.1200
Volume5 984 636
Financials
Sales 2018 81 273 M
EBIT 2018 24 895 M
R. net 2018 16 036 M
Debt 2018 12 563 M
Rend. 2018 2,83%
P/E ratio 2018 18,32
P/E ratio 2019 16,47
EV / Sales 2018 4,31x
EV / Sales 2019 4,05x
Capitalization 338 B
Company
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices.The Consumer segment includes products used in the baby care,...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-08-27 JOHNSON & JOHNSON : Ex-dividend day for
Trading Rating :
Investor Rating :
Latest news
07/21JOHNSON & JOHNSON : to Present New Data for Investigational Preventive Vaccine, Single-Tablet Treatment Regimens for HIV-1 at AIDS 2018
AQ
07/21JOHNSON & JOHNSON : Janssen gets indication expansion approval to treat CLL/ SLL
AQ
07/20JOHNSON & JOHNSON : Zach attack tames cold and wet Carnoustie
AQ
07/20JOHNSON & JOHNSO : johnson, & johnson
PU
07/20JOHNSON & JOHNSON : Janssen Pharmaceutical - Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA is Being Stopped Early for Positive Efficacy Findings
AQ
07/20JOHNSON & JOHNSON : Announces Quarterly Dividend for Third Quarter 2018
AQ
07/20Eversight Expands Offer Innovation Suite to Address $760 Billion Consumer Packaged Goods Market
AQ
07/20JOHNSON & JOHNSON : BioCentury - Provention raises $64M IPO
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBearishBearish
Resistance129132134
Spread/Res.-2,5%-4,5%-5,9%
Spread/Supp.0,93%5,4%3,8%
Support125119121